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Abstract: The asymmetric intramolecular alkylation of chiral aro- 
matic aldimines, in which differentially substituted alkenes are teth- 
ered meta to the imine, was investigated. High enantioselectivities 
were obtained for imines prepared from aminoindane derivatives, 
which hnction as directing groups for the rhodium-catalyzed C-H 
bond activation. Initial demonstration of catalytic asymmetric in- 
tramolecular alkylation also was achieved by employing a sterically 
hindered achiral imine substrate and catalytic amounts of a chiral 
amine. 
Key words: C-H bond activation, asymmetric catalysis, transimi- 
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The intramolecular alkylation of aromatic imines via 
rhodium-catalyzed ortho-directed C-H bond activation' 
provides an efficient route to functionalized bicyclic ring 
systems.' A catalytic and highly enantioselective variant 
of this intramolecular alkylation has been achieved for 
some alkene substitution patterns using chiral phosphor- 
amidite l i g a n d ~ . ~  However, for other alkene s~~bstitution 
patterns, alternative approaches for achieving asymmetric 
induction may be necessary. In the context of the first total 
synthesis of (+)-lithospermic a ~ i d , ~ , ~  the first example of 
employing a chiral imine as a directing group in catalytic 
C-H bond activation was developed. Specifically, imine 
2, prepared by condensation of 1 with R-(-)-aminoindane, 
was cyclized to give product 3 in 76% ee after auxiliary 
hydrolysis (Scheme 1). Herein, improved chiral imine di- 
recting groups are reported and evaluated with substrates 
containing different alkene substitution patterns.4 
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In previously published work, we evaluated a range of 
structurally diverse chiral amine directing groups, with 
aminoindane proving to be most effective. Therefore, to 
further increase the stereoselectivity of the intramolecular 
alkylation reaction, we chose to evaluate substituted ami- 
noindane derivatives, which were synthesized from the 
corresponding indanones by one-pot reductive amination 
with tert-butanesulfinamide (Scheme 2 and Scheme 3).6' 
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Scheme 2 Asymmetric synthesis of chiral aminoindane derivatives 
6 and 7 
Condensation of tert-butanesulfinamide with 7-fluoro- 
indanone7 and 7-methylindanone and subsequent reduc- 
tion of the N-tert-butanesulfinyl imines with NaBH, 
provided sulfinamides 4 and 5 with dr > 99: 1. The modest 
yields observed in these reactions are presumably the 
result of competing enamine formation in the imine 
condensation step (Scheme 2). Subsequent removal of 
the tert-butanesulfinyl group under acidic conditions 
provided the enantiomerically pure amines 6 and 7. 
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Scheme 1 Asymmetric cyclization of lithospermic acid precursor & ",,,r - HCI & 
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Scheme 3 Asymmetric synthesis of chiral7-phenylaminoindane 10 
For the introduction of a phenyl group in position 7 of the 
aminoindane, 7-bromo-aininoindanone7 was subjected to 
Suzuki cross coupling under conditions described by 
Buchwalds to provide 8 in high yield (Scheme 3). At- 
tempted condensation of ketone 8 with te7.t-butanesulfin- 
amide using Ti(OEt), resulted in Meenvein-Pondorf- 
Verley (MPV) reduction to give the undesired corre- 
sponding alcohol byproduct. Therefore, Ti(OPh),,g which 
is not capable of participating in MPV reduction, was used 
instead of Ti(OEt), and provided sulfinamide 9 with high 
selectivity albeit in modest yield. Removal of the teut- 
butanesulfinyl group under acidic conditions gave enan- 
tiolnerically pure ainine 10. 
Each 7-substituted 2-aminoindane was condensed with 
aldehyde 1 to obtain the corresponding chiral ilnines 2 and 
11-13. Using optimized conditions with ferrocenyl-PCy, 
(FcPCy?) as the ligand, the rhodium-catalyzed intra- 
molecular alkylation led, after hydrolysis, to dihydro- 
benzofiran 3 with good yields and improved 
enantioselectivity (Table 1). The enantioselectivity pro- 
vided by the 7-fluoroaininoindane chiral auxiliary at 90% 
ee was particularly impressive (entry 3). 
We next focused our efforts on the asymmetric alkylation 
of substrates with different alkene substitution patterns to 
explore the scope of this method. Cyclization of substrates 
14 and 15 with a phenyl group in place of the 3,4- 
dimethoxyphenyl group proceeded in good yields but 
with appreciable reduction in enantioselectivity (Table 2). 
Iinines 17-20 with 1,l- and 1,2-disubstituted double 
bonds, respectively, were also evaluated (Table 3). Con- 
version of the corresponding aldehyde into chiral imines 
17 and 18 followed by cyclization provided dihydrofuran 
21 in quantitative yield after auxiliary hydrolysis. Once 
Table 1 Asymmetric Cyclization of Chiral Imines 2, 11-13 
1) 10 mol% [ R h C l ( c ~ e ) ~ ] ~  




OMe Ar = 3,4-dimethoxyphenyl 
2,11-13 3 
Entry Imine R Temp Time Yield ee 
("C) (h) (%) (%)" 
a Enantiomeric excess determined by chiral HPLC after hydrolysis of 
imine with 1 M HC1 (aq). 
Includes trace amounts of trans diastereomer. 
Table 2 Asymmetric Cyclization of Chiral Imines 14 and 15 
1) 10 mol% [RhCl(coe):!lz 






Entry Imine R Temp Time Yield ee 
("C) (11) (%) (%)" 
1 14 H 75 16 80 65 
2 15 F 75 16 8 1 70 
Enantiomeric excess determined by chiral HPLC after hydrolysis of 
imine with 1 M HC1 (aq). 
Table 3 Asymmetric Cyclization of Chiral Imines 17-20 
r=-, 
1) 10 mol% [RhCl(coe)z]p 
30 mol% FcPCy2 
toluene 
2) HCI R2 
Entry Imine R' R2 R3 Yield ee Product 
Yields based on 'H NMR integration relative to 2,6-dimethoxy- 
toluene as an internal standard. 
Enantiomeric excess determined by chiral HPLC after hydrolysis of 
imine with 1 M HC1 (aq). 
again, 7-fluoro-aminoindane provided the highest 
enantiomeric excess (entry 2). In contrast, ilnines 19 and 
20, prepared from the 1,2-disubstituted aldehyde, cyclized 
significantly less efficiently, with product 22 being ob- 
tained in lower yield and with lower enantioselectivity 
(entries 3 and 4). 
Additionally, asymmetric cyclization of an achiral imine 
through imine exchangelo using catalytic amounts of 
chiral amine was investigated. Effective imine exchange 
was first demonstrated by cyclization of achiral N-te1.t-bu- 
tyl aldimine 23 upon addition of one equivalent of chiral 
aminoindane (Table 4, entry 1). The enantiomeric purity 
of the product aldehyde 21 establishes that transirnination 
Table 4 Catalytic Asymmetric Cyclization of Achiral Imine 24 
through Imine Exchange 
toluene, 75 "C, 16 h bolt 2) H.1
Entry Imine X (mol%) Y (mol%) Yield (%) ee (%)" 
2 23 3 0 10 75 45 
' Enantiomeric excess was determined by chiral HPLC after 
hydrolysis of imine with 1 M HC1 (aq). 
occurs considerably faster than cyclization of the sterical- 
ly hindered achiral imine, which would lead to racemic 
product. Catalytic asymmetric cyclization of 23 was next 
demonstrated by addition of 30 mol% of chiral aminoin- 
dane along with 10 mol% SC(OT~)~,  which was required 
to accelerate the imine exchange process. Only a minor 
drop in the yield and enantiomeric excess of product 22 
was observed (entry 2). 
In conclusion, asymmetric intramolecular alkylation of 
chiral aromatic aldiinines was evaluated for differentially 
substituted alkene substrates. The highest enantioselectiv- 
ities were obtained using the 7-fluoro-aminoindane as the 
chiral auxiliary with cyclization providing product in 90% 
ee for the most favorable substrate. Additionally, initial 
demonstration of catalytic asyinlnetric intranlolecular 
alkylation was accoillplished by employing a sterically 
hindered achiral imine substrate and catalytic amounts of 
a chiral amine. 
Unless otherwise noted, materials were obtained from co~mnercial 
suppliers and used without further purification. THF was distilled 
under N? from sodium benzophenone ketyl, pyridine from CaH2, 
and MeOH from Mg(MeO), immediately prior to use. Degassed 
toluene was purified by passage through an activated alumina col- 
umn. All organic reactions were performed under an atmosphere of 
N, in flame-dried or oven-dried glassware unless otherwise stated. 
All C-H activation experiments were prepared in an N,-filled Vac 
inert atmosphere box. The following compounds were prepared ac- 
cording to referenced literature procedures: [RhCl(coe),]," and 
FcPCy2.I2 Thin-layer cluomatography was performed on Merck 60 
F254 250 pm silica gel plates. Visualization of the developed chro- 
matogram was performed by fluorescence quenching, KMn04 
stain, or p-anisaldehyde stain. Flash chromatography was camed 
out according to the general procedure of StillL3 using Merck 60 
230-240 mesh silica gel or basic AI10, (activity grade I) as noted. 
Organic extracts were dried over MgSOj or Na,S04 and were con- 
centrated using a Biichi rotary evaporator under high vacuum pres- 
s u e .  Melting points were determined on a Mel-Temp apparatus and 
are uncorrected. Unless othenvise noted, 'H NMR and I3C NMR 
spectra were obtained in CDC1,. NMR chemical shifts are reported 
in ppm and referenced to residual protonated solvent. Mass spectra 
were performed by the University of California, Berkeley Micro- 
Mass Facility. Chiral HPLC analyses were performed on an Agilent 
1100 system with a Chiral PAK AS column (250 mm 4.6 mm) with 
a flow rate of 1 mL11nin and with i-PrOH-hexanes as the mobile 
phase. A Perkin-Elmer 241 polarimeter with a sodium lamp was 
used to determine specific rotations and concentrations are reported 
in g1dL. 
Imine Formation 
To a 25 mL round-bottom flask equipped with a magnetic stir bar 
and septum was added 1.00 mmol of aldehyde, benzene (10 mL), 
MS 4 A (1.0 g), and 1.1 equiv of amine (1.10 mmol). The reaction 
flask was then equipped with a reflux condenser, and the mixture 
was heated to reflux for 12 11. The reaction mixture was cooled to 
r.t., diluted with benzene, dried over Na2S04, filtered, and concen- 
trated. 
Cyclization of Aromatic Irnines 
In a dry box, a solution of [RhCl(~oe)~], (3.59 mg, 5 pmol, 0.1 
equiv) and FcPCy, (5.73 mg, 15.0 pmol, 0.3 equiv) in toluene-d, 
(0.25 mL) was added to a solution of i~nine (50.0 pmol, 1.0 equiv) 
in toluene (0.25 mL) and then transferred to an NMR tube. The tube 
was sealed, and the solution was stirred at 75 "C for 16 11. The reac- 
tion solution was cooled to r.t., transferred to a round-bottom flask 
with EtOAc rinses, and concentrated under reduced pressure. The 
residue was washed with 1 N HC1 (aq) and stirred for 20 rnin. The 
mixture was diluted with EtOAc, the layers were separated, and the 
aqueous layer was extracted with EtOAc. The combined organic 
layers were dried, filtered, and concentrated under reduced pres- 
sure. The crude material was chromatographed on SiO,. 
Deprotection of tert-Butanesulfinamide Derivatives 
To the tert-butanesulfinamide derivatives was added 1:l (vlv) 
MeOH and HCI-dioxane solution (4 M, 3 equiv). The mixture was 
stirred at r.t. for 30 min and then concentrated to near dryness. The 
amine hydrochloride was precipitated in a mixture of MeOH and 
tert-butyl methyl ether. The precipitate was then filtered off and 
washed with tei-t-butyl methyl ether. The amine llydrochloride was 
dissolved in 1 N NaHCO, solution, which was subsequently ex- 
tracted three times with EtOAc. The combined organic layers were 
dried over MgS04, filtrated, and concentrated to provide each 
amine in quantitative yields. 
3-(3,4-Dimethoxyphenyl)-3-[5-(indan-l-yliminomethyl)-2- 
rnethoxyphenoxy]acrylic Acid Methyl Ester (2) 
This compound was prepared according to the general procedure for 
imine formation with 1 equiv of aldehyde (18.6 mg, 0.0500 mmol) 
and 1.5 equiv of amine (7.32 mg, 0.0550 mmol). 'H NMR (400 
MHz, CDCI,): 6= 8.18 (s, 1 H, CH=NCH), 7.38 (d, 1 H, J =  8.4 Hz, 
ArH), 7.3 1-7.11 (m, 6 H, ArH x 6), 7.00 (d, 1 H, J= 7.3 Hz, ArH), 
6.90 (d, 1 H, J =  8.4Hz, ArH), 6.73 (d, I H, J =  8.5 Hz, ArH), 5.97 
(s, 1 H, CHCO,CH,), 4.78 (t, 1 H, J =  7.2 Hz, CH,CHN=CH), 3.93 
(s, 3 11, OCH3), 3.79 (s, 3 H, OCH3), 3.76 (s, 3 H, OCH3), 3.64 (s, 3 
H, CG,CH,), 3.07-3.01 (m, 1 H, one ofArCH2CH2), 2.92-2.84 (m, 
1 H, one of ArCH2CH2), 2.39-2.35 (m, 1 H, one of ArCH,CH,), 
2.19-2.09 (m, 1 H, one of ArCH2CH,). "C NMR (100 MHz, 
CDCI,): 6 =  164.6, 162.6, 159.0, 151.3, 150.8, 148.6, 146.0, 144.1, 
143.4, 129.2, 128.0, 127.2, 126.0, 124.4, 124.0, 124.0, 120.5,116.1, 
111.6, 110.6, 109.5, 103.6, 74.5, 55.8, 55.5, 55.4, 50.9, 33.9, 30.7. 
7.7 (c 1.12, CH,CI,). HRMS-FAB: i71h calcd for C,,H,,NO, 
[M + HI": 488.2073; found: 488.2079. 
2-Methylpropane-2-sulfinic Acid (7-Fluoroindan-1-y1)arnide 
(4) 
To a 25 mL round-bottom flask equipped with a magnetic stir bar 
and septum were added 7-fluoroindan-I-one (190 mg, 1.23 mmol), 
2 equiv of (R)-2-methylpropane-2-sulfinic acid amide (297 mg, 
2.45 mmol), and 2.5 mL of THF. Under argon atmosphere, 4 equiv 
of Ti(OEt), (1.12 g, 4.90 mmol) was added to the reaction mixture. 
The reaction flask was then equipped with a reflux condenser and 
the mixture was heated to reflux for 12 h. The reaction mixture was 
cooled to -78 OC and 4 equiv of NaBH, (185 mg, 4.90 mmol) was 
added. The reaction mixture was stirred for 30 min at -78 "C and al- 
lowed to warm to r.t. The reaction mixture was quenched with NaCl 
solution, and the precipitate was filtered off and washed with 
EtOAc. After phase separation, the aqueous phase was extracted 
with EtOAc. The combined organic phases were washed with brine, 
dried over Na,SO,, filtered, and concentrated. The crude material 
was chromatographed on SiO, (10-50% EtOAc-hexanes) to afford 
compound 4 as a yellow oil (120 mg, 0.470 mmol, 38%). IHNMR 
(400 MHz, CDCI,): 6 = 7.19-7.14 (m, 1 H, Arm, 6.97 (d, 1 H, 
J=7.2Hz,ArH),6.81(t, lH,J=8.8Hz,ArH),5.08-5.05(m, l H ,  
HNCHCH,CH,), 3.76 [br s, 1 H, NHS(0)t-Bu], 3.11-3.03 (m, 1 H, 
one of ArCH,CH,), 2.86-2.79 (m, 1 H, one of ArCH2CH,), 2.44- 
2.35 (m, 1 H, one of ArCH,CH,), 2.19-2.11 (m, 1 H, one of 
ArCH,CH,), 1.12 [s, 9 H, C(CH,),]. I3C NMR (100 MHz, CDCI,): 
6 = 160.5, 158.0, 147.5, 147.4, 130.1, 130.1, 128.9, 128.8, 120.5, 
120.4, 113.2, 113.0,56.7,56.7,55.3,33.3.30.6,30.6,22.2(multiple 
C's coupled to F). [a]," -6.1 (c 2.8, CH,CI,). HRMS-FAB: miz 
calcd for C,,HlgFNOS [M + HI+: 256.1 171; found: 256.1171. 
Propane-2-sulfinic Acid (7-Methylindan-1-y1)amide (5) 
To a 25 mL. round-bottom flask equipped with a magnetic stir bar 
and septum were added 7-methylindan-1-one (179 mg, 1.23 mmol), 
2 equiv of (R)-2-methylpropane-2-sulfinic acid amide (297 mg, 
2.45 mmol), and 2.5 inL of THF. Under argon atmosphere, 4 equiv 
of Ti(OEt), (1.12 g, 4.90 mmol) was added to the reaction mixture. 
The reaction flask was then equipped with a reflux condenser and 
the mixture was heated to reflux for 12 h. The reaction mixture was 
cooled to -78 "C and 4 equiv of NaBH, (1 85.4 mg, 4.90 mmol) was 
added. The reaction mixture was stirred for 30 min at -78 "C and al- 
lowed to warm to r.t. The reaction nlixture was quenched with NaCl 
solution, and the precipitate was filtered off and washed with 
EtOAc. After phase separation, the aqueous phase was extracted 
with EtOAc. The combined organic phases were washed with brine, 
dried over Na2S04, filtered, and concentrated. The crude material 
was chromatographed on Si0, (10-50% EtOAc-hexanes) to afford 
compound 5 as a white solid (73.9 mg, 0.294 mmol, 24%); mp 67- 
68 "C. 'H NMR (400 MHz, CDC1,): 6 = 7.17 (t, 1 H, J =  7.2 Hz, 
ArH),7.08(d,lH,J=7.6Hz,ArH),6.99(d,lH,J=7.2Hz,ArH), 
4.94 @r s, 1 H, HNCHCH,CH,), 3.18-3.09 [m, 2 H, NHS(0)t-Bu, 
one of ArCH,CHz]. 2.83-2.77 (m, 1 H, one of ArCH,CH,), 2.37 (s, 
3 H, ArCIX,), 2.21-2.16 (m, 2 H, ArCH,CH,), 1.15 [s, 9 H, 
C(CH,),]. I3C NMR (100 MHz, CDCI,): 6 = 145.0, 141.3, 134.5, 
128.8, 128.0, 122.2,58.2,55.3,33.6,30.3,22.4, 18.4. [ ~ ] , ~ ~ - 9 . 2 ( c  
1.5, CH,Cl,). HRMS-FAB: m/z calcd for C,,H,,NOS [M + HIf: 
252.1422; found: 252.1422. 
Amines 6 and 7 were prepared according to the general procedure 
for the deprotection of tei-t-butanesulfinamide derivatives. 
7-Fluoroindan-1-ylamine (6) 
'H NMR (400 MHz, CDCI,): 6 = 7.18-7.1 1 (m, 1 H, ArH), 6.96 (d, 
1 H, J= 10.0Hz,ArH),6.82(t, 1 H , J =  12.0Hz,ArH),4.63 (t, 1 
H, J =  8.4 Hz, H,NCHCH,), 3.08-3.01 (m, 1 H, one of ArCH,CHJ, 
2.86-2.76 (m, 1 H, one of ArCH,CH,), 2.25-2.41 (m, 1 H, one of 
ArCH2CH2), 1.95-1.75 (m, 3 H, one of ArCH2CH2, NH,). "C NMR 
(100 MHz, CDCI,): 6 = 161.2, 158.7, 146.7, 146.6, 133.3, 133.1, 
129.3, 129.2, 120.5, 113.2, 113.0,55.0,35.5,30.6(multipleCs cou- 
pled to F). [a],I5 -0.4 (c 3.5, CH,Cl,). 
7-Methylindan-1-ylamine (7) 
'H NMR (400 MHz, CDCI,): 6 = 7.17-7.05 (m, 2 H, ArH x 2), 6.99 
(d, 1 H, J=9 .2  Hz, ArH), 4.504.46 (dd, 1 H, J=9.6,  3.6 Hz, 
HINCHCH2), 3.17-3.06 (m, 1 H, one of ArCH,CH,), 2.84-2.75 (m, 
1 H, one of ArCH,CH,), 2.40 (s, 3 H, ArCH,), 2.40-2.29 (m, 1 H, 
one of ArCH2CH2), 1.96-1.88 (m, 1 H, one of ArCH,CH,), 1.55 (br 
s, 2 H, NH,). I3CNMR (100 MHz, CDCI,): 6 = 145.3, 143.2, 133.9, 
127.9, 127.7, 122.3, 55.9, 35.7, 30.2, 18.4. [a],'5 -2.08 (c 0.5, 
CH,Cl,). 
7-Phenylindnn-1-one (8) 
In a dry box, 7-bromoindan-1-one (105 mg, 0.500 nunol), 3 equiv 
ofKF (87.2 mg, 1.50 mmol), 1.5 equiv ofphenylboronic acid (91.5 
mg, 0.750 mmol), 1 mol% of Pd(OAc), (1.1 mg, 0.0050 mmol), 
2 mol% of biphP(1-Bu), (3.0 mg, 0.010 mmol), and 0.5 mL of THF 
were added to a Schlenk flask. The flask was sealed, and the solu- 
tion was stirred at 80 "C for 14 11. The reaction solution was cooled 
to r.t., diluted with EtOAc, and washed with brine and H,O. The 
aqueous layer was extracted with EtOAc, and the combined organic 
layers were dried, filtered, and concentrated under reduced pres- 
sure. The crude material was cl~romatographed on SiO? (0-10% 
EtOAc-hexanes) to afford compound 8 as a white solid (76.0 mg, 
0.365 mmol, 73%); mp 91-92 "C. 'HNMR (400 MHz, CDCI,): 6 = 
7.60(t, lH,J=7.6Hz,ArH),7.52-7.4l(m,6H,ArH~6),7.28(d, 
1 H, J =  7.6 Hz, ArH), 3.16-3.13 (m, 2 H, ArCH,CH,), 2.71-2.68 
(m, 2 H, ArCH,CH,). I3C NMR (100 MHz, CDCI,): 6 = 205.2, 
156.1,141.1, 137.8, 133.6, 132.7, 129.1, 129.1, 127.5, 127.4, 125.5, 
36.6, 25.0. HRMS-FAB: n~/z calcd for CI5H,,O [M + HIf: 
209.0966; found: 209.0966. 
2-Methylpropane-2-sulfinic Acid (7-phenylindan-1-y1)amide 
(9) 
To a 25 mL round-bottom flask equipped with a magnetic stir bar 
and septum were added 7-phenylindan-1-one (200 mg, 0.960 
mmol), 2 equiv of (R)-2-n1ethylpropane-2-sulfinic acid amide (233 
mg, 1.92 mmol), and 2.5 mL. of THF. Under an argon atmosphere, 
4 equiv of Ti(OPh), (1.61 g, 3.84 mmol) was added to the reaction 
mixture. The reaction flask was then equipped with a reflux con- 
denser, and the mixture was heated to reflux for 12 h. The reaction 
mixture was then cooled to -78 "C, and 4 equiv ofNaBH, (145 mg, 
3.84 mnmol) were added. The reaction mixture was stirred for 30 min 
at -78 "C and allowed to warm to r.t. The reaction mixture was 
quenched with NaCl solution, and the precipitate was filtered off 
and washed with EtOAc. After phase separation, the aqueous phase 
was extracted with EtOAc. The combined organic phases were 
washed with brine, dried over Na,SO,, filtered, and concentrated. 
The crude material was chromatographed on SiO, (1040% 
EtOAc-hexanes) to afford compound 9 as a white solid (95.0 mg, 
0.303 mmol, 32%); mp 109-110 'C. 'H NMR (400 MHz, CDCI,): 
6=7.51-7.45(m,4H,ArHx4),7.36-7.41(m,lH,ArH),7.33(d, 
1 H, J = 7 . 6  Hz, ArH), 7.27-7.29 (~n,  1 H, ArH), 7.18 (d, 1 H, 
J=7.2Hz,ArH),5.29(t, 1 H,J=6.OHz,HNCHCH2),3.42[s, l H ,  
NHS(0)t-Bu], 3.14-3.08 (m, 1 H, one of ArCH,CH,), 3.01-2.93 
(m, 1 H, one ofArCH,CH,), 2.60-2.53 (m, 1 H, one of ArCH,CH,), 
2.14-2.07 (m, 1 H, one of ArCHJH,), 0.89 [s, 9 H, C(CH,),]. I3c 
NMR (100 MHz, CDCI,): 6 = 144.8, 140.4, 139.7, 138.6, 129.0, 
128.4,128.4, 127.8, 127.8, 124.0,57.3,54.8,32.7,30.5,22.1. [aIDZ5 
-16.8 (c 0.6, CH,Cl,). KRiviS-FAB: mniz calcd for ClgH24NOS 
[MI+: 314.1579; found: 314.1579. 
7-Phenylindan-1-ylamine (10) 
This compound was prepared according to the general procedure for 
the deprotection of tei-t-butanesulfinamide derivatives. IH NMR 
(400 MHz, CDC1,): 6 = 7.49-7.44 (m, 4 H, ArH x 4), 7.38-7.36 (m, 
1H,ArH),7.31-7.22(m,2H,ArHx2),7.07(d,lH,J=10.0Hz, 
ArH), 4.74 (t, 1 H, J =  8.4 Hz, H2NCHCH2), 3.1G3.08 (m, 1 H, one 
of ArCH2CH,), 3.13-3.03 (m, 1 H, one of ArCHZCH2), 2.9k2.84 
(m, 1 H, one ofArCHzCHz), 2.562.43 (m, 1 H, one of ArCH,CH,), 
1.81-1.70 (m, 1 H, one of ArCHICH2), 1.47 (br s, 2 H, NH,). I3C 
NMR (100 MHz, CDCI,): 6 = 143.9, 140.8, 138.7, 128.6, 128.3, 
127.8, 127.7, 127.2, 124.0, 56.1, 35.2, 30.2. [a],15 -3.5 (c 3.5, 
CH,Cl,). 
3-(3,4-Dimethoxyphenyl)-3-{2-methoxy-5-[(7-methylindan-l- 
ylirnino)methyl]phenoxy}acrylic Acid Methyl Ester (11) 
This compound was prepared according to the general procedure for 
imine synthesis with 1 equiv of aldehyde (18.6 mg, 0.0500 mmol) 
and 1.5 equiv of amine (8.1 mg, 0.0550 mmol). [H NMR (400 MHz, 
CDCI,): 6 =  8.08 (s, 1 H, CH=NCH), 7.33 (d, 1 H, J =  8.5 Hz,ArH), 
7.20-7.18(m,2H,ArHx2),7.15-7.09(m,3H,ArHx3),6.94(d, 
lH,J=7.0Hz.ArH),6.80(d,  lH,J=8.5Hz,ArH),6.77(d,  l H ,  
J= 8.5 Hz, ArH), 5.96 (s, 1 H, CHCO,CH,), 4.98-4.95 (m, 1 H, 
CH,CHN=CH), 3.96 (s, 3 H, OCH,), 3.90 (s, 3 H, OCH,), 3.79 (s, 
3 H. OCH,), 3.67 (s, 3 H, CO,CH,), 3.14-3.10 (m, 1 H, one of 
ArCH,CHI), 2.89-2.86 (m, 1 H, one ofArCH,CHz), 2.39-2.34 (m, 
1 H, one of ArCH,CH,), 2.10 (s, 3 H, ArCHJ, 2.06-2.02 (m, 1 H, 
one of ArCH2CH,). I3C NMR (100 MHz, CDCI,): 6 = 165.0, 162.9, 
158.2,151.4,151.0, 148.8, 146.2, 144.6, 142.0, 135.4, 129.6, 128.3, 
127.9,127.8,126.4, 124.1, 122.2, 120.7, 116.3,111.8, 110.8,109.8, 
103.9, 73.7, 56.1, 55.9, 55.7, 51.2, 33.9, 31.0, 18.8. [u],?~ +4.2 (c 
2.0, CH2Cl1). 
3-(3,4-Dimethoxyphenyl)-3-{5-[(7-fluoroindan-l-ylimino)meth- 
yll-2-methoxyphenoxy)acrylic Acid Methyl Ester (12) 
In a dry box, 1 equiv of aldehyde (20.8 mg, 0.0559 mmol), 1.1 equiv 
of amine (9.3 mg, 0.0615 mmol), and 0.5 mL ofbenzene were com- 
bined in a vial and stirred overnight at r.t. The resulting reaction 
mixture was diluted wit11 2 mL of EtzO, filtered through Celite, and 
concentrated to yield a colorless oil (28.0 mg, 0.0554 mrnol, 99%). 
IH NMR (400 MHz, CDCI,): 6 = 8.16 (s, 1 H, CH=NCH), 7.38- 
7.36 (m, 2 H, ArH x 2), 7.27-7.10 (m, 3 H, ArH x 3), 7.04 (d, 1 H, 
J =  7.2 Hz, ArH), 6.90 (d, 1 H, J =  8.4 Hz, ArH), 6.82-6.76 (m, 2 
H, ArHx2), 5.96 (s, 1 H, CHCO,CH,), 5.05 (m, 1 H, 
CHICHN=CH), 3.95 (s, 3 H, OCH,), 3.87 (s, 3 H, OCH,), 3.79 (s, 
3 H, OCH,), 3.67 (s, 3 H, CO,CH,), 3.21-3.17 (m, 1 H, one of 
ArCH,CH,), 2.95-2.85 (m, 1 H, one of ArCH,CH2), 2.45-2.35 (m, 
1 H, one of ArCH,CH,), 2.25-2.15 (m, 1 H, one of ArCH,CH,). I3C 
NMR (100 MHz, CDCl,): 6 = 165.0, 163.0, 161.6, 159.1, 151.4, 
151.0, 148.7,148.1,148.0, 146.1, 130.1, 130.0, 129.7, 129.7, 129.5, 
128.3,126.3,124.0,120.7,120.4, 120.4,116.7,113.2, 113.0, 111.8, 
110.8, 109.7, 103.7, 71.6, 71.6, 56.1, 56.0, 55.9, 55.8, 55.7, 51.2, 
34.0, 31.4 (multiple C's coupled to F). 
3-(3,4-Dirnethoxyphenyl)-3-{2-methoxy-5-[(7-phenylindan-l- 
ylimino)methyl]phenoxy}acrylic Acid Methyl Ester (13) 
This compound was prepared according the general procedure for 
imine synthesis with 1 equiv of aldehyde (18.6 mg, 0.0500 mmol) 
and 1.5 equiv of amine (11.5 mg, 0.0550 mmol). 'H NMR (400 
MHz, CDCI,): 6 = 7.37-7.05 (m, 13 H, ArH x 12, CH=NCH), 6.83 
(m, 2 H, ArH x 2), 5.96 (s, 1 H, CHCOZCH,), 4.93 (m, 1 H, 
CH,CHN=CH), 3.94 (s, 3 H, OCH,), 3.87 (s,3 H, OCH,), 3.79 (s, 
3 H, OCH,), 3.69 (s, 3 H, CO2CH,), 3.20-3.18 (m, 1 H, one of 
ArCH,CH,), 3.00-2.90 (m, 1 H, one ofArCH,CHz), 2.41-2.32 (m, 
1 H, one of ArCH2CH,), 2.15-2.00 (m, 1 H, one of ArCH,CH,). 
[IZ],'~ f7.7 (c 1.5, CH2Clz). 
2-(3,4-Dimethoxyphenyl)-4-formyl-7-methoxy-2,3-dihydroben- 
zofuran-3-carboxylic Acid Methyl Ester (3) 
The C-H activation reactions of imines 2 and 11-13 were per- 
formed following the general procedure for the cyclization of aro- 
matic imines. The crude material was chromatographed on SiO, (2- 
50% EtOAc-hexanes) to afford compound 6 as a white solid with 
yields and ee as described in the text. The ee was determined by 
HPLC analysis; mp 119-120 OC. 'H NMR (400 MHz, CDCI,): 6 = 
9.82(s, 1 H, CHO),7.39 (d, 1 H, J=8 .3  Hz,ArH),6.98 (d, 1 H, 
J = 8 . 3  Hz, ArH), 6.96-6.62 (m, 2 H, ArHxZ), 6.82 (d, 1 H, 
J =  8.2, ArH), 6.00 (d, 1 H, J= 10.2 Hz, ArOCHAr), 4.89 (d, 1 H, 
J =  10.2 Hz, ArCHCO,CH,), 3.97 (s, 3 H, OCH,), 3.85 (s, 3 H, 
OCH,), 3.84 (s, 3 H, OCH,), 3.23 (s, 3 H, CO,CH,). I3C NMR (100 
MHz, CDCI,): 6 = 190.6, 169.7, 149.9, 149.5, 149.0, 148.5, 128.7, 
128.2, 126.4, 125.3, 119.4, 111.5, 110.3, 109.4, 87.7, 56.0, 55.8, 
55.7, 54.1, 51.7. [u],'~ -1 12.9 (c 0.95, CH,Cl,). HRMS-FAB: ndz 
calcd for C,,H,,O, [MI': 372.1209; found: 372.1213. HPLC analy- 
sis [AS column, hexanes-i-Pr0H (70:30), 40 min run time]: peak 1, 
t ,  = 16.6 min (minor enantiomer) and peak 2, t, = 3 1.0 min (major 
enantiomer). 
3-(3-Formy1phenoxy)-3-phenylacrylic Acid Methyl Ester 
To a sealed tube equipped with a magnetic stir bar was added 
MeOH (42 mL) followed by Na metal (1.58 g, 68.8 mmol, 1.6 
equiv, cut into small pieces). Once all the Na had dissolved, isovan- 
illin (48.4 g, 3 18 mmol, 7.6 equiv) was added, and the reaction mix- 
ture became a thick, yellow slurry. After stining at r.t. for 5 min, 
pyridine (42 mL) was added, followed by phenylpropynoic acid 
methyl ester (5.00 g, 43.0 mmol, 1.0 equiv), and the reaction mix- 
ture was stirred at 120 OC for 1.75 11. The mixture was cooled to r.t., 
diluted with EtOAc, and sat. aqNH4Cl solution was added. The lay- 
ers were separated, and the organic layer was washed several times 
with sat. aq K,CO, solution to remove excess isovanillin. The com- 
bined organic layers were dried, filtered, and concentratedunder re- 
duced pressure. The crude material was cluomatographed on basic 
alumina (0-20% EtOAc-hexane) to afford the Z-akene as a white 
solid (5.20 g, 18.4 mmol, 42%); mp 98-99 "C. 'H NMR (400 MHz, 
CDCI,): S = 9.68 (s, 1 H, CHO), 7.57 (dd, 2 H, J= 2.0, 6.4 Hz, 
ArH), 7.45 (dd, 1 H, J =  2.0, 8.4 Hz, ArH), 7.35-7.25 (m, 4 H, 
J=2 .0  Hz, ArH), 7.00 (d, 1 H, J =  8.4 Hz, ArH), 6.15 (s, 1 H, 
CHCO,Me), 4.00 (s, 3 H, OCH,), 3.64 (s, 3 H, OCH,). I3C NMR 
(100 MHz, CDCI,): 6 = 190.2, 164.3, 162.1, 154.4, 146.5, 133.1, 
130.8, 129.7, 128.7, 127.5, 126.8, 114.9, 111.5, 105.8, 56.2, 51.2. 
HRMS-FAB: m/' calcd for CIBHI7O5 [M + HIf: 3 13.1076; found: 
313.1076. 
3-[5-(Indan-l-yIiminomethyl)-2-methoxyphenoxy]-3-phenyl- 
acrylic Acid Methyl Esters (14) 
This compound was prepared according to the general procedure for 
i~nine synthesis with 1 equiv of aldehyde (14.1 mg, 0.0500 mmol) 
and 1.5 equiv of amine (7.3 mg, 0.0550 mmol). 'H NMR (400 MHz, 
CDCI,): 6 = 8.20 (s, 1 H, CH=NCH), 7.59 (d, 2 H, J =  7.6 Hz, 
ArHxZ), 7.43 (d, 1 H, J =  8.0 Hz, ArH), 7.37-7.32 (m, 3 H, 
ArHx3), 7.20-7.16(m,4H,ArHx4),7.02 (d, 1 H,J=7.6Hz,  
ArH), 6.93 (d, 1 H, J =  8.4 Hz, ArH), 6.05 (s, 1 H, CHCO,CH,), 
4.8 1 (t, 1 H, J =  7.2 Hz, CH,CHN=CH), 3.98 (s, 3 H, OCH,), 3.68 
(s, 3 H, OCH,), 3.12-3.07 (m, 1 H, one of ArCH,CH,), 2.94-2.88 
(m, 1 H, one ofArCH,CH,), 2.45-2.39 (m, 1 H, one of ArCHzCH,), 
2.20-2.15 (m, 1 H, one of ArCH,CH,). ',C NMR (100 MHz, 
CDCI,): 6 =  164.9, 163.0, 159.1, 151.4, 148.1, 146.0, 133.9, 130.5, 
129.7, 129.4, 128.6, 127.1, 123.9,120.4, 120.4,116.6, 113.2, 113.1, 
112.0, 105.1, 71.6, 56.2, 51.3, 34.1, 31.4. [ u ] ~ ~ ~  +1.3 (c 2.9, 
CH2Cl,). 
3-{5-[(7-Fluoroindan-1-ylimino)methyl]-2-methoxyphenoxy}- 
3-pi~enyiucryiic Acid lvierhyi Ester (15) 
This compound was prepared according to the general procedure for 
imine synthesis w ~ t h  1 equiv of aldehyde (14.1 mg, 0.0500 mmol) 
and 1.5 equiv of amine (8.3 mg, 0.0550 mmol). 'H NMR (400 MHz, 
CDCI,): 6 = 8.12 (s, 1 H, CH=NCH), 7.59 (d, 2 H, J =  6.8 Hz, 
ArH x2), 7.36-7.27 (m, 4 H, ArHx4), 7.18-7.13 (m, 2 H, 
ArHx2),7.02(d, 1 H,J=5.6Hz,ArH),6.87(d,  l H ,  J=6.8Hz,  
ArH), 6.78 (t, 1 H, J= 6.8Hz,ArH), 6.00(s, 1 H,CHCO,CH,), 5.03 
(m, 1 H, CH,CHN=CH), 3.92 (s, 3 H, OCH,), 3.65 (s, 3 H, OCH,), 
3.20-3.14 (m, 1 H, one of ArCH2CH,), 2.89-2.85 (m, 1 H, one of 
ArCH,CH,), 2.40-2.36 (m, 1 H, one of ArCH,CH,), 2.17-2.14 (m, 
1 H, one of ArCH2CHz). I3C NMR (100 MHz, CDCI,): 6 = 164.8, 
162.9, 159.4, 151.5, 146.1,144.4,143.7, 130.6,129.4,128.6,127.4, 
127.1, 126.3, 124.7, 124.3, 123.9, 116.4, 111.9, 105.3, 74.7, 56.2, 
51.3, 34.2, 30.9 (multiple C's coupled to F). +1.8 (c 1.1, 
CH2C12). 
7-Formyl-4-methoxy-2-phenylindan-1-carboxylic Acid Methyl 
Ester (16) 
The C-H activation reactions of imines 14 and 15 were performed 
following the general procedure for the cyclization of aromatic imi- 
nes. The crude material was chromatographed on SiO, (2-30% 
EtOAc-hexanes) to afford compound 16 as a white solid with yields 
and ee as described in the text. The ee was determined by KPLC 
analysis; mp 135-136 "C. IH NMR (400 MHz, CDCI,): 6 = 9.82 (s, 
1 H, CHO), 7.41-7.28 (m, 6 H, ArH x 6), 6.99 (d, 1 H, J =  8.4 Hz, 
ArH), 6.07 (d, 1 H, J =  10.4 Hz, ArOCHAr), 4.95 (d, 1 H, J =  10.0 
Hz, ArCHC02CH3), 3.97 (s, 3 H, OCH,), 3.13 (s, 3 H, OCH,). I3C 
NMR (100 MHz, CDCl,): S = 190.7, 169.5, 150.4, 149.6, 136.0, 
128.8, 128.51, 128.1, 126.6, 126.5, 125.3, 111.7, 87.8, 56.2, 54.3, 
51.6. HRMS-FAB: riih calcd for CI8Hl6O5 [MIf: 312.0998; found: 
312.0998. HPLC analysis [AS column, hexane-i-PrOH (75:25), 45 
min run time]: peak 1, t, = 10.8 min (minor enantiomer) and peak 
2, t, = 20.0 min (major enantiomer). 
3-Isopropenyloxybenzaldehyde 
To a 100 mL round-bottom flask equipped with a magnetic stir bar 
and septum were added 1.5 equiv (7.98 g, 24.6 mmol) of Cs,CO,, 
0.25 equiv of CuCl(405 mg, 4.10 mmol), 0.5 equiv of acetylacetone 
(819 mg, 8.19 mmol), and 50 mL of THF. The suspension was 
stirred for 5 min at r.t. Under an argon atmosphere, 3-hydroxyben- 
zaldehyde (2.0 g, 16.38 mmol) and 1.3 equiv of 2-bromopropene 
(1.86 mL, 21.29 mmol) were added to the reaction mixture. The re- 
action flask was then equipped with a reflux condenser, and the 
mixture was heated to reflux for 12 h. The reaction mixture was 
cooled to r.t., filtered, and concentrated under reduced pressure. The 
cmde material was chromatographed on SiO, (0-10% EtOAc-hex- 
anes) to afford the title compound as a yellow oil (690 mg, 4.26 
mmol, 26%). 'H NMR (400 MHz, CDC1,): 6 = 9.92 (s, 1 H, CHO), 
7.56(dd, 1 H , J =  1.2, lO.OHz,ArH), 7.49(t, 1 H, J =  1.6Hz,ArH), 
7.44(t, lH,J=7.6Hz,ArH),7.24(dd, 1 H , J =  1.2, 10.8Hz,ArH), 
4.23 (d, 1 H, J =  2.0 Hz, CH2=CCH3), 3.99 (d, 1 H, J =  2.0 Hz, 
CH,=CCH,), 1.93 (s, 3 H, CH2=CCH3). I3C NMR (100 MHz, 
CDCI,): 6 =  191.3, 158.7, 156.0, 137.8, 130.0, 126.4, 125.2, 120.1, 
91.5, 19.5. HRMS-FAB: m/z calcd for C,,HI,O, [MIf: 162.0681; 
found: 162.068 1. 
3-Propenylorybenzaldehyde 
To a 100 mL round-bottom flask equipped with a magnetic stir bar 
and septum were added 1.5 equiv (7.98 g, 24.6 mmol) of Cs2C0,, 
0.25 equiv of CuCl(405 mg, 4.10 mmol), 0.5 equiv of acetylacetone 
(819 mg, 8.19 mmol), and 50 mL of THF. The suspension was 
stirred for 5 min at r.t. Under an argon atmosphere, 1 equiv of 3- 
[1,3]dioxolan-2-yl-phenol(2.72 g, 16.38 mmol) and 1.5 equiv of 1- 
bromopropene were added to the reaction mixture. The reaction 
flask was then equipped with a reflux condenser and the mixture 
was heated to reflux for 12 h. The reaction mixture was cooled to 
r.t., filtered, and concentrated under reduced pressure. The acetal 
 as hydro1;zed by stimng in 6 N HCl-MeGI-I for 1 11. The mixture 
was extracted with EtOAc and concentrated, and the crude material 
was chromatographed on SiOl (610% EtOAc-hexanes) to afford 
the E-alkene as a yellow oil (584 mg, 3.60 mmol, 22%). 'H NMR 
(400 MHz, CDCI,): S = 9.90 (s, IH, CHO), 7.45 (dd, 1 H, J =  1.2, 
8.0 Hz, ArH), 7.41-7.37 (m, 2 H, Arm, 7.16 (dd, 1 H, J =  1.2, 5.2 
Hz, ArH), 6.40-6.35 (m, 1 H, CH3CH=CH), 5.42-5.34 (m, 1 H, 
CH,CH=CH), 1.63 (dd, 3 H, J= 1.6, 6.8 Hz, CH,CH=CH). I3C 
NMR (100 MHz, CDC1,): 6 = 191.6, 157.8, 140.9, 137.7, 130.1, 
124.4, 122.6, 114.9, 109.9, 12.1. HRMS-FAB(+): m/z calcd for 
CI,HI,O~ [MIf: 162.0681; found: 162.0680. 
Imines 17-20 were prepared according to the general procedure for 
imine synthesis. 
Indan-1-yl-(3-isopropenyloxybenzylidene)amine (17) 
One equiv of aldehyde (8.1 mg, 0.0500 mmol) and 1.5 equiv of 
amine (7.32 mg, 0.0550 mmol) were condensed. 'H NMR (400 
MHz, CDCI,): 6 = 8.43 (s, 1 H, CH=NCH), 7.55 (d, 1 H, J =  7.6 Hz, 
ArH), 7.51 (s, 1 H, Arm, 7.39 (t, 1 H, J =  8.0 Hz, ArH), 7.30 (d, 1 
H, J = 7 . 2  Hz, ArH), 7.26-7.13 (m, 2 H, ArHxZ), 7.12 (m, 2 H, 
ArH x 2), 4.95 (t, 1 H, J =  7.2 Hz, CH,CHN=CH), 4.21 [s, 1 H, one 
of CH2=C(0)CH,], 4.01 [s, 1 H, one of CH,=C(O)CH,], 3.18-3.12 
(m, 1 H, one of ArCH,CH,j, 3.02-2.94 (m, 1 H, one of ArCH2CH,), 
2.53-2.47 (m, 1 H, one of ArCH,CH,), 2.32-2.23 (m, 1 H, one of 
ArCH,CH2), 2.00 (s, 3 H, CH,). I3C NMR (100 MHz, CDCI,): S = 
159.8,159.4,155.7,144.1,143.8, 138.0,129.6,127.6,126.4 124.8, 
124.3, 124.0, 123.0, 120.1,90.3,74.9,34.2,31.0,20.0. [~], '~+14.6 
(c 1.0, CH,Cl,). 
(7-Fluoroindan-l-yl)-(3-isopropenyloxybenzylidene)amine (18) 
One equiv of aldehyde (8.3 mg, 0.0500 rnmol) and 1.5 equiv of 
amine (7.3 mg, 0.0550 mmol) were condensed. 1HNMR(400 MHz, 
CDCI,): 6 = 8.48 (s, 1 H, CH=NCH), 7.50-7.43 (m, 2 H,ArH x 2), 
7.34 (t, 1 H, J =  10.4 Hz, ArH), 7.25-7.17 (m, 1 H, ArH), 7.09-7.05 
(m,2H,ArHx2),6,82(t ,  1 H , J =  11.2Hz,ArH),5.17-5.15(m, 1 
H, CH,CHN=CH), 4.17 [s, 1 H, one of CH,=C(O)CH,], 3.97 Is, 1 
H, one of CH,=C(O)CH,], 3.30-3.20 (m, 1 H, one of ArCH,CH,), 
2.99-2.89 (m, 1 H, one of ArCH,CH,), 2.51-2.41 (m, 1 H, one of 
ArCH,CH,), 2.29-2.23 (m, 1 H, one of ArCH,CH2), 1.97 (s, 3 H, 
CH,). [a]," 52.2 (c 1.3, CH,Cl,). 
Indan-1-yl-(3-propenyloxybenzylidene)amine (19) 
One equiv of aldehyde (8.1 mg, 0.0500 rnmol) and 1.5 equiv of 
amine (7.3 mg, 0.0550 mmol) were condensed. IHNMR (400 MHz, 
CDCI,): 6 = 8.43 (s, 1 H, CH=NCH), 7.49 (s, 1 H, ArH), 7.43 (d, 1 
H, J=6.0Hz,ArH),7.36 (t, 1 H, J=6.0Hz,ArH),7.32 (d, 1 H, 
J =  5.6 Hz, ArH), 7.26 (t, 1 H, J =  5.2 Hz, ArH), 7.21 (t, 1 H, J =  6.0 
Hz,ArH), 7.12 (d, 1 H, J=5.6Hz,ArH), 7.07 (d, 1 H, J=6.0Hz,  
ArH), 6.49 [d, 1 H, J =  9.6 Hz, HC(CH,)=CHOAr], 5.45-5.38 [m, 
1 H, HC(CH,)=CHOAr], 4.96 (t, 1 H, J =  5.6 Hz, CH,CHN=CH), 
3.18-3.13 (m, 1 H, one of ArCH2CHl), 3.02-2.96 (m, 1 H, one of 
ArCH2CH,), 2.51-2.49 (m, 1 H, one of ArCH,CH,), 2.33-2.26 (m, 
1 H, one of ArCH,CH,), 1.69 (d, 3 H, J =  5.6 Hz, CH,). 13C NMR 
(100 MHz, CDC1,): 6 = 160.0, 157.7, 144.1, 143.8, 141.7, 137.8, 
129.7, 127.6, 126.4, 124.8, 124.3, 123.0, 119.1, 114.6, 108.7, 74.9, 
34.2,31.0, 12.2. [a]D'5+2.1 (c 1.9, CH,Cl,). 
(7-Fluoroindan-l-yl)-(3-propenyloxybenzylidene)amine (20) 
One equiv of aldehyde (8.1 1 mg, 0.05 mmol) and 1 .5 equiv of amine 
(8.31 mg, 0.055 nunol) were condensed. 'H NMR (400 MHz, 
CDCI,): 5 = 8.39 (s, 1 H, CH=NCH), 7.40-7.37 (m, 2 H, ArH x 2), 
7.32(t, lH,J=7.6Hz,ArH),7.25-7.16(m, 1 H,ArH),7.08(d, 1 
H, J =  7.2 Hz, ArH), 7.02 (d, 1 H, J= 8.0 Hz, ArH), 6.84 (t, 1 H, 
J = 8.8 Hz, ArH), 6.46 [d, 1 H, J = 12.4 Hz, HC(CH,)=CHOAr], 
5.41-5.36 [m, 1 H, HC(CH,)=CHOAr], 5.18-5.17 (m, 1 H, 
CH2CHN=CH), 3.3 1-3.23 (m, 1 R, one of ArCH,CH,), 2.98-2.97 
(m, 1 H, one of ArCH,CH,), 2.52-2.47 (m, 1 H, one of ArCH,CH,), 
2.29-2.28 (m, 1 H, one of ArCH?CH,), 1.68 [d, 3 H, J= 6.8 Hz, 
C(CH,),]. I3C XMR (100 MHz, CDCI,): 6 = 159.9, 159.2, 157.7, 
148.2. 148.1, 141.7, 137.9, 130.0, 129.9, 129.9, 129.6, 122.9, 120.5, 
120.5, 119.0, 114.8, 113.3, 113.1, 108.6,71.8,34.1,31.5,31.5, 12.3 
(multiple C's coupled to F). [a],15 +6.0 (c 1.0, CH,CI,). 
The C-H activation reactions of imines 17-20 were prepared fol- 
lowing the general procedure for the cyclization of aromatic imines. 
The crude material was chromatographed on SiO, (0-1% EtOAc- 
hexanes) to afford compounds 21 and 22 as colorless oils with 
yields and ee as described in the text. The ee was determined by 
HPLC analysis. 
2-Methyl-2,3-dihydrobenzofuran-4-carbnldehyde (21) 
'H NMR (400 MHz, CDCI,): 6 = 10.03 (s, 1 H, CHO), 7.30-7.26 
(m, 2 H, ArH x 2), 7.01-6.98 (m, 1 H, ArH), 5.06-4.97 [m, 1 H, 
CH,CH(CH,)OAr], 3.70-3.64 [dd, 1 H, J =  17.6, 8.8 Hz, one of 
CH,CH(CH,)OAr], 3.15-3.09 [dd, 1 H, J =  17.6, 7.6 Hz, one of 
CH,CH(CH?)OAr], 1.48 (d, 3 H, J =  6.0 Hz, CH3CH). I3C NMR 
(100 MHz, CDCL,): 6 = 192.5, 160.6, 132.9, 128.5, 128.0, 124.1, 
114.7, 80.7, 36.8, 21.8. HPLC analysis [AS column, hexanes- 
i-PrOH (99:1), 20 min run time]: peak 1, t, = 9.3 min (minor enan- 
tiomer) and peak 2, t, = 8.9 min (major enantiomer). 
3-MethyI-2,3-dihydrobenzofuran-4-carbatdehyde (22) 
'H NMR (400 MHz, CDCI,): 6 = 10.06 (s, 1 H, CHO), 7.367.28 
(m, 2H ,ArHx2) ,  7.05-7.02 (m, 1 H,ArH), 4.60 [t, 1 H, J =  11.2 
Hz, CH,CH(CH,)OAr], 4.34-4.29 [m, 1 H, one of 
CH,CH(CH,)OAr], 3.98-3.92 [m, 1 H, one of CH,CH(CHJOAr], 
1.30 (d, 3 H, J=  9.2 Hz, CH3CH). I3C NMR (100 MHz, CDC1,): 
6=192.1, 160.6, 133.4, 132.7, 128.7, 124.8, 115.2,79.3,36.1,20.5. 
HPLC analysis [AS column, hexanes-i-PrOH (99:1), 20 min run 
time]: peak 1, t, = 10.0 min (minor enantiomer) and peak 2, t, = 8.9 
min (major enantiomer). 
tcrt-Butyl-(3-isopropenyloxybenzy1idene)amine (23) 
Imine 23 was prepared following the general procedure for imine 
formation. 'H NMR (400 MHz, CDCI,): 6 = 8.22 (s, 1 H, 
CH=NCH), 7.49 (d, 1 H, J= 7.6 Hz, ArH), 7.44 (s, 1 H, ArH), 
7.34 (t, 1 H, J=8.0Hz,ArH),  7.06 (d, 1 H, J=7.6Hz,ArH),4.17 
[s, 1 H, one of CH,=C(CH,)OAr], 3.97 [s, 1 H, one of 
CH2=C(CH3)OAr], 1.98 (s, 3 H, CCH,), 1.28 [s, 9 H, C(CH,),]. I3C 
NMR (100 MHz, CDCl,): 6 = 159.4, 155.6, 154.4, 138.9, 129.5, 
123.5, 122.5, 119.8, 89.9, 57.3,29.6,20.0. HRMS-FAB: ~n/icalcd 
for C,,H,,NO [M + HI+: 218.1545; found: 218.1545. 
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